Biosimilar Index is a comprehensive drug intelligence service that provides a robust, dynamically updated and highly-detailed insight into the status of leading biosimilar and NCB assets in development worldwide, making it one of the most comprehensive analyses of its type providing both on-going tracking of development and interpretation of the commercial and clinical significance.